(Pleuritis pleurisy )
8,424 results
  • "LAPAGE Index In Differentiating Tuberculous Pleurisy and Malignant Pleural Effusion". [Journal Article]
    Am J Med Sci. 2026 Aug 15. [Online ahead of print]Kirac A, Kahriman B, … Satici CAJ
  • CONCLUSIONS: In patients with pleural effusion and ADA levels ≥ 40 U/L, neither the cancer ratio nor the pleural LDH/ADA ratio alone provided sufficient discriminatory power between malignant pleural effusion and tuberculous pleurisy. The LAPAGE index may serve as a useful adjunctive tool in the differential diagnosis of tuberculosis and malignancy in pleural effusions with high ADA levels.
  • Utility of cell-free DNA in diagnosing tuberculous pleurisy: A systematic review and meta-analysis protocol. [Journal Article]
    PLoS One. 2026; 21(8):e0355485.Shen Y, Du K, … Yao LPlos
  • CONCLUSIONS: This review will provide pooled estimates of the diagnostic sensitivity and specificity of cfDNA for tuberculous pleurisy, evaluate its clinical utility, and identify key factors-such as sample type, detection technology, and pre-analytical procedures-associated with optimal performance. The findings will offer high-level evidence to guide clinical application and future research. Systematic review registration: PROSPERO Registration number: CRD420261424501.
  • Diagnostic performance and safety of image-guided pleural biopsy and medical thoracoscopy for undiagnosed exudative pleural effusion: a systematic review and network meta-analysis. [Systematic Review]
    Eur Respir Rev. 2026 Apr; 35(180).Lyu S, Zheng Z, … Hou GER
  • CONCLUSIONS: Closed pleural biopsy consistently has a low diagnostic yield and is not recommended as a first-line biopsy method for patients with undiagnosed exudative pleural effusions. Rigid medical thoracoscopy offers distinct clinical value for a complete visual inspection, large biopsies, and potential pleurodesis, particularly in suspected mesothelioma cases. The currently available evidence does not support the routine replacement of semirigid medical thoracoscopy with cryobiopsy. Computed tomography-guided biopsy may be preferred in cases involving thickening ≥10 mm or small target lesions. Conversely, ultrasound-guided biopsy may be appropriate for lesions measuring ≥3 mm with a clear acoustic window. UE-guided pleural biopsy shows promise as an emerging option, although the evidence is limited. In tuberculous pleurisy, medical thoracoscopy may offer higher diagnostic sensitivity in certain settings, particularly in high-prevalence areas. The current evidence is insufficient to establish a clear advantage for any biopsy method regarding the overall complication risk.
  • Management of inflammatory cardiopulmonary manifestations in systemic lupus erythematosus: a systematic review. [Systematic Review]
    Adv Rheumatol. 2026 May 29; 66(1).Hao Y, Montes R, … Nikpour MAR
  • CONCLUSIONS: GC and conventional IS currently remain the most evidence-based approaches for managing most cardiopulmonary manifestations in SLE. Despite aggressive immunosuppressive therapies, patients with some conditions, such as LM, ALP, and DAH, still experience high mortality. The quality of the existing evidence and the insights into novel therapies in these patients were limited, highlighting the urgent need for RCTs and optimized management in this area.
  • Uncovering the Anti-Pleurisy Mechanism of Shizao Decoction via Network Pharmacology and Molecular Docking. [Journal Article]
    Curr Drug Discov Technol. 2026 May 16. [Online ahead of print]Huang S, Zeng S, … Lu HCD
  • CONCLUSIONS: The active ingredients of Shizao Decoction exert therapeutic effects on pleurisy by modulating T cell receptor and C-type lectin receptor signaling pathways through key targets (IL-6, TNF, IL-1β, STAT3, IL-2, NFKB1). These ingredients directly regulate pleurisy-specific pathophysiological processes, including pleural capillary permeability, inflammatory cell infiltration, and effusion formation, participate in immune responses, and exert anti-inflammatory and antiviral effects. The findings not only clarify the therapeutic mechanism of Shizao Decoction for pleurisy but also provide a theoretical basis for its clinical application and the development of new therapeutic strategies for pleurisy.
  • Crafty Tuberculous Pleurisy Presented With Hydropneumothorax in a 49-Year-Old Male: A Case Report. [Journal Article]
    Clin Case Rep. 2026 May; 14:e72731.Mansour M, Dakkak T, … Hasan MYCC
  • A 49-year-old male presented with acute dyspnea and hydropneumothorax. Imaging and biopsy confirmed pleural tuberculosis. Despite atypical features and no risk factors, anti-tuberculosis therapy led to rapid improvement. This case highlights the diagnostic challenge of distinguishing tuberculosis-related hydropneumothorax from necrotizing bacterial pneumonia and empyema in the presence of complex…